Security
MiMedx Group, Inc Common Stock · MDXG
MDXGNASDAQCommon stockCurrentCIK 1376339Updated Oct 29, 2026
MDXG price & chart
Loading TradingView…
NASDAQ:MDXG on TradingView ↗About the company
Surgical Markets Offer a Large, Expanding Opportunity Outside of Wound Care 1 - Life Science Intelligence, U.S. Surgical Procedure Volumes Database: inpatient and outpatient procedures, 2024. 2 - Calculated using Definitive Healthcare Database, LSI Procedural Data, published orthopedic market research data and related journals, surgeon validation, and Sanara estimates. | 13 | LARGE SURGICAL MARKET ~92 million Surgical procedures performed in the US each year1 ~23 million General surgery procedures performed in the US each year1 +$4B Incremental addressable market unlocked by the Sanara acquisition2 GROWING MIMEDX PRESENCE 15% Surgical sales growth based upon LTM Q3:26 vs. LTM Q3:25 8 studies Underway across surgical disciplines, with 5 published since May 2025 Expanding Offering Non-placental derived products, like HELIOGEN® and G4Derm® Plus augmenting Surgical growth Surgical Complications Burden Providers and Payors, Creating Demand for Products That Improve Outcomes
In the news
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG ↗
MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference ↗
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG ↗
Recent filings
425 filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
10-Q filing
425 filing
Other Events
Items 8.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 318,988,000Source | 243,891,000Source | 280,998,000Source | 291,109,000Source | 230,183,000Source | 308,676,000Source | 270,420,000Source | 221,681,000Source | 342,653,000Source | 263,915,000Source | 239,047,000Source | 171,430,000Source |
| GoodwillUSD | 19,441,000Source | 19,441,000Source | 19,441,000Source | 19,441,000Source | 19,441,000Source | 19,441,000Source | 19,441,000Source | 19,441,000Source | 19,441,000Source | 19,441,000Source | 19,441,000Source | 19,976,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 11,147,000Source | 11,201,000Source | 12,086,000Source | 12,028,000Source | 12,047,000Source | 13,140,000Source | 11,062,000Source | 12,550,000Source | 14,158,000Source | 11,626,000Source | 5,257,000Source | 5,852,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 142,083,000Source | 88,801,000Source | 135,839,000Source | 118,869,000Source | 69,037,000Source | 159,773,000Source | 106,431,000Source | 48,487,000Source | 166,121,000Source | 104,416,000Source | 82,000,000Source | 65,950,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 78,186,000Source | 54,030,000Source | 41,297,000Source | 69,228,000Source | 52,798,000Source | 46,034,000Source | 62,288,000Source | 57,016,000Source | 75,707,000Source | 55,828,000Source | 53,871,000Source | 43,084,000Source |
| Inventory, NetUSD | 26,502,000Source | 24,249,000Source | 20,931,000Source | 24,890,000Source | 25,056,000Source | 26,228,000Source | 24,070,000Source | 24,454,000Source | 25,340,000Source | 23,807,000Source | 21,021,000Source | 13,183,000Source |
| Assets, CurrentUSD | 254,095,000Source | 172,139,000Source | 205,365,000Source | 220,876,000Source | 154,018,000Source | 240,326,000Source | 200,112,000Source | 138,853,000Source | 277,471,000Source | 191,886,000Source | 164,261,000Source | 134,198,000Source |
| Operating Lease, Right-of-Use AssetUSD | 4,668,000Source | 2,843,000Source | — | 4,987,000Source | 3,175,000Source | — | 5,299,000Source | 3,499,000Source | 4,344,000Source | 5,606,000Source | 2,132,000Source | 3,400,000Source |
| Other Assets, NoncurrentUSD | 2,987,000Source | 1,180,000Source | 11,897,000Source | 990,000Source | 1,239,000Source | 6,886,000Source | 1,048,000Source | 1,251,000Source | 7,274,000Source | 1,106,000Source | 205,000Source | 148,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 80,042,000Source | 62,883,000Source | 64,995,000Source | 74,485,000Source | 62,143,000Source | 65,740,000Source | 67,644,000Source | 65,950,000Source | 86,105,000Source | 70,808,000Source | 96,330,000Source | 96,924,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Common Stock, Value, IssuedUSD | 148,000Source | 147,000Source | 149,000Source | 148,000Source | 147,000Source | 149,000Source | 148,000Source | 148,000Source | 148,000Source | 147,000Source | 146,000Source | 114,000Source |
| Additional Paid in CapitalUSD | 296,670,000Source | 279,558,000Source | 297,094,000Source | 291,096,000Source | 274,685,000Source | 296,328,000Source | 286,864,000Source | 280,000,000Source | 299,081,000Source | 284,219,000Source | 276,249,000Source | 173,804,000Source |
| Retained Earnings (Accumulated Deficit)USD | -57,872,000Source | -98,697,000Source | -68,381,000Source | -74,620,000Source | -106,792,000Source | -53,541,000Source | -84,236,000Source | -124,417,000Source | -42,681,000Source | -91,259,000Source | -133,678,000Source | -191,906,000Source |
| Stockholders' Equity Attributable to ParentUSD | 238,946,000Source | 181,008,000Source | 216,003,000Source | 216,624,000Source | 168,040,000Source | 242,936,000Source | 202,776,000Source | 155,731,000Source | 256,548,000Source | 193,107,000Source | 142,717,000Source | -17,988,000Source |
| Liabilities and EquityUSD | 318,988,000Source | 243,891,000Source | 280,998,000Source | 291,109,000Source | 230,183,000Source | 308,676,000Source | 270,420,000Source | 221,681,000Source | 342,653,000Source | 263,915,000Source | 239,047,000Source | 171,430,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 57,682,000Source | 41,941,000Source | 38,498,000Source | 50,290,000Source | 40,012,000Source | 44,550,000Source | 42,619,000Source | 42,221,000Source | 64,266,000Source | 45,595,000Source | 46,008,000Source | 43,557,000Source |
| Operating Lease, Liability, CurrentUSD | — | — | — | — | — | — | — | — | 1,320,000Source | 1,307,000Source | 1,495,000Source | 1,391,000Source |
| Accounts Payable, CurrentUSD | 11,415,000Source | 6,924,000Source | 8,293,000Source | 8,499,000Source | 7,603,000Source | 11,464,000Source | 8,868,000Source | 9,697,000Source | 14,528,000Source | 7,409,000Source | 9,048,000Source | 8,847,000Source |
| Operating Lease, Liability, NoncurrentUSD | — | — | — | — | — | — | — | — | 3,245,000Source | 4,705,000Source | 893,000Source | 2,381,000Source |
| Other Liabilities, NoncurrentUSD | 5,521,000Source | 2,924,000Source | 10,791,000Source | 6,984,000Source | 3,882,000Source | 5,096,000Source | 7,492,000Source | 5,276,000Source | 5,372,000Source | 7,383,000Source | 2,223,000Source | 4,773,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 12,825,000Source | 8,396,000Source | 11,140,000Source | 15,105,000Source | 9,281,000Source | 11,008,000Source | 9,447,000Source | 9,196,000Source | 11,383,000Source | 9,012,000Source | 9,361,000Source | 11,024,000Source |
| Long-term Debt, Excluding Current Maturities | — | — | — | — | — | — | — | — | —Source | —Source | —Source | —Source |
| Long-term Debt, Current MaturitiesUSD | 1,375,000Source | 1,000,000Source | 1,500,000Source | 1,250,000Source | 1,000,000Source | 1,500,000Source | 1,125,000Source | 1,000,000Source | 1,500,000Source | 1,000,000Source | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 16,839,000Source | 18,018,000Source | 15,706,000Source | 17,211,000Source | 18,249,000Source | 16,094,000Source | 17,533,000Source | 18,453,000Source | 16,467,000Source | 17,830,000Source | 48,099,000Source | 48,594,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | — | — | 14,881,000Source | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | -1,696,000Source | 4,262,000Source | 16,396,000Source | 16,933,000Source | 16,959,000Source | 12,666,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -28,209,000Source | 7,203,000Source | 26,394,000Source | 2,552,000Source | 12,237,000Source | 5,550,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 889,000Source | 263,000Source | 1,533,000Source | 2,357,000Source | 7,838,000Source | 1,794,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 1,936,000Source | 1,460,000Source | 2,119,000Source | -1,410,000Source | 783,000Source | 1,053,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 8,710,000Source | 12,472,000Source | -40,777,000Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 1,879,000Source | 5,299,000Source | 74,003,000Source | 66,198,000Source | 26,775,000Source | -17,893,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -5,642,000Source | -406,000Source | -6,886,000Source | -9,583,000Source | -2,155,000Source | -2,660,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | — | — | — | — | — | — | 2,089,000Source | 38,000Source | — | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | — | — | — | 1,987,000Source | — |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 1,901,000Source | 2,458,000Source | 3,118,000Source | 2,641,000Source | 0Source | 1,190,000Source |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 9,515,000Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -2,585,000Source | -2,878,000Source | -5,412,000Source | -34,199,000Source | -8,570,000Source | -580,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | — | — | — | — | — | 0Source | -137,000Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -6,348,000Source | 2,015,000Source | 61,705,000Source | 22,416,000Source | 16,050,000Source | -21,133,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 142,083,000Source | 88,801,000Source | 135,839,000Source | 118,869,000Source | 159,773,000Source | 106,431,000Source | 166,121,000Source | 104,416,000Source | 82,000,000Source | 65,950,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 318,000Source | 343,000Source | 1,246,000Source | 2,698,000Source | 6,034,000Source | 4,569,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 8,508,000Source | 3,247,000Source | -548,000Source | — |
| Additional Financial Items | ||||||||||||
| Accretion ExpenseUSD | — | — | — | — | — | — | — | — | 200,000Source | — | — | — |
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | — | — | 16,396,000Source | 16,933,000Source | 16,959,000Source | 12,666,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | — | 135,000Source | — | — | 505,000Source | 467,000Source |
| Amortization of Intangible AssetsUSD | — | — | 112,000Source | 192,000Source | 291,000Source | 100,000Source | 301,000Source | 99,000Source | 439,000Source | 765,000Source | 762,000Source | 701,000Source |
| Asset Retirement Obligation, Accretion ExpenseUSD | — | — | — | — | — | — | — | 24,000Source | — | — | 93,000Source | 92,000Source |
| DepreciationUSD | — | — | 572,000Source | 580,000Source | 441,000Source | 558,000Source | 528,000Source | 558,000Source | 2,264,000Source | 2,279,000Source | 2,665,000Source | 3,345,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | 0Source | — | — | -15,000Source | 17,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | 0Source | 0Source | -1,401,000Source | — | 0Source |
| General and Administrative ExpenseUSD | — | — | 15,281,000Source | 11,795,000Source | — | 16,284,000Source | 9,319,000Source | 13,108,000Source | 56,513,000Source | 49,525,000Source | — | — |
| GoodwillUSD | — | — | 19,441,000Source | 19,441,000Source | 19,441,000Source | 19,441,000Source | 19,441,000Source | 19,441,000Source | 19,441,000Source | 19,441,000Source | 19,441,000Source | 19,976,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | 0Source | 298,000Source | — | 0Source | — | 0Source | 0Source | 446,000Source | 0Source | 0Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | 16,748,000Source | 7,878,000Source | — | — | -10,860,000Source | 7,023,000Source | 48,578,000Source | 41,998,000Source | 67,439,000Source | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | 0Source | 217,000Source | — | 0Source | — | 0Source | 0Source | 421,000Source | -9,211,000Source | — |
| Income Tax Expense (Benefit)USD | — | — | 6,101,000Source | 3,541,000Source | -2,940,000Source | 3,389,000Source | -4,471,000Source | 1,589,000Source | 17,684,000Source | 15,296,000Source | -36,806,000Source | 206,000Source |
| InterestExpenseNonoperatingUSD | — | — | 425,000Source | 521,000Source | — | 475,000Source | 402,000Source | 478,000Source | 1,783,000Source | 3,938,000Source | — | — |
| Inventory Write-downUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Investment Income, InterestUSD | — | — | 1,210,000Source | 799,000Source | — | 1,213,000Source | 1,288,000Source | 984,000Source | 4,716,000Source | 2,932,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | 16,748,000Source | 8,095,000Source | -14,840,000Source | 9,618,000Source | -10,860,000Source | 7,023,000Source | 48,578,000Source | 42,419,000Source | 58,228,000Source | -30,197,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | — | -36,777,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -126,000Source | -21,000Source | -102,000Source | -101,000Source | -168,000Source | -145,000Source | -558,000Source | -565,000Source | -26,000Source | -4,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | 0Source | 0Source | 1,397,000Source | 997,000Source | 651,000Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 113,725,000Source | 84,057,000Source | 64,362,000Source | 98,605,000Source | 58,991,000Source | 88,205,000Source | 418,630,000Source | 348,879,000Source | 321,477,000Source | 267,841,000Source |
| Cost of RevenueUSD | — | — | 18,719,000Source | 15,322,000Source | 19,981,000Source | 18,681,000Source | 17,368,000Source | 16,558,000Source | 73,013,000Source | 60,073,000Source | 54,634,000Source | 48,316,000Source |
| Selling, General and Administrative ExpenseUSD | — | — | 69,001,000Source | 53,516,000Source | 59,779,000Source | 64,151,000Source | 53,231,000Source | 59,969,000Source | 266,194,000Source | 225,087,000Source | 211,124,000Source | 208,789,000Source |
| Operating Income (Loss)USD | — | — | 22,190,000Source | 11,162,000Source | -18,466,000Source | 12,370,000Source | -16,049,000Source | 8,251,000Source | 63,887,000Source | 58,865,000Source | 37,116,000Source | -24,971,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -126,000Source | -21,000Source | -102,000Source | -101,000Source | -168,000Source | -145,000Source | -558,000Source | -565,000Source | -26,000Source | -4,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 22,849,000Source | 11,419,000Source | -17,780,000Source | 13,007,000Source | -15,331,000Source | 8,612,000Source | 66,262,000Source | 57,294,000Source | 30,633,000Source | -29,991,000Source |
| Income Tax Expense (Benefit)USD | — | — | 6,101,000Source | 3,541,000Source | -2,940,000Source | 3,389,000Source | -4,471,000Source | 1,589,000Source | 17,684,000Source | 15,296,000Source | -36,806,000Source | 206,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 16,748,000Source | 8,095,000Source | -14,840,000Source | 9,618,000Source | -10,860,000Source | 7,023,000Source | 48,578,000Source | 42,419,000Source | 58,228,000Source | -30,197,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0.11Source | 0.05Source | -0.1Source | 0.07Source | -0.07Source | 0.05Source | 0.33Source | 0.29Source | 0.4Source | -0.33Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0.11Source | 0.05Source | -0.1Source | 0.06Source | -0.07Source | 0.05Source | 0.32Source | 0.28Source | 0.37Source | -0.33Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 148,035,283Source | 146,958,986Source | 147,795,741Source | 147,761,332Source | 148,446,017Source | 147,272,324Source | 147,793,069Source | 146,979,354Source | 116,495,810Source | 112,909,266Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 149,713,653Source | 148,373,631Source | 147,795,741Source | 149,317,281Source | 148,446,017Source | 149,677,452Source | 149,724,507Source | 149,049,197Source | 145,962,462Source | 112,909,266Source |
| Interest Expense (non-operating)USD | — | — | 425,000Source | 521,000Source | — | 475,000Source | 402,000Source | 478,000Source | 1,783,000Source | 3,938,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 112,000Source | 192,000Source | 291,000Source | 100,000Source | 301,000Source | 99,000Source | 439,000Source | 765,000Source | 762,000Source | 701,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 8,974,000Source | 2,824,000Source | 998,000Source | 206,000Source |
| General and Administrative ExpenseUSD | — | — | 15,281,000Source | 11,795,000Source | — | 16,284,000Source | 9,319,000Source | 13,108,000Source | 56,513,000Source | 49,525,000Source | — | — |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Gross ProfitUSD | — | — | 95,006,000Source | 68,735,000Source | 44,381,000Source | 79,924,000Source | 41,623,000Source | 71,647,000Source | 345,617,000Source | 288,806,000Source | 266,843,000Source | 219,525,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | 16,748,000Source | 7,878,000Source | — | — | -10,860,000Source | 7,023,000Source | 48,578,000Source | 41,998,000Source | 67,439,000Source | — |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | 0.11Source | 0.05Source | — | 0.07Source | — | 0.05Source | 0.33Source | 0.29Source | 0.48Source | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | 0.11Source | 0.05Source | — | 0.06Source | — | 0.05Source | 0.32Source | 0.28Source | 0.43Source | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | 0Source | 217,000Source | — | 0Source | — | 0Source | 0Source | 421,000Source | -9,211,000Source | — |
| Interest Income (Expense), NetUSD | — | — | — | — | — | — | — | — | — | — | -6,457,000Source | -5,016,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | 785,000Source | 278,000Source | 788,000Source | 738,000Source | 886,000Source | 506,000Source | 2,933,000Source | -1,006,000Source | — | — |
| Investment Income, InterestUSD | — | — | 1,210,000Source | 799,000Source | — | 1,213,000Source | 1,288,000Source | 984,000Source | 4,716,000Source | 2,932,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | — | -36,777,000Source |
| Net Income (Loss) from Continuing Operations Available to Common Shareholders, BasicUSD | — | — | 16,748,000Source | 7,878,000Source | — | 9,618,000Source | — | 7,023,000Source | 48,578,000Source | 41,998,000Source | 55,796,000Source | — |
| Preferred Stock Dividends and Other AdjustmentsUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 11,643,000Source | 6,580,000Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | — | — | 0Source | — | — | — | — | 0Source | 0Source | 6,753,000Source | — |
| Research and Development ExpenseUSD | — | — | 3,703,000Source | 2,918,000Source | 2,777,000Source | 3,303,000Source | 4,140,000Source | 3,328,000Source | 15,097,000Source | 12,341,000Source | 12,665,000Source | 22,829,000Source |
| Selling and Marketing ExpenseUSD | — | — | 53,720,000Source | 41,721,000Source | — | 47,867,000Source | 43,912,000Source | 46,861,000Source | 209,681,000Source | 175,562,000Source | — | — |
Offerings
Registration 333-298540
Filing attachments
ea030210501ex99-2.htm · S-4 · 2026-08-25
EX-99.2 5 ea030210501ex99-2.htm CONSENT OF TRUIST SECURITIES, INC Exhibit 99.2 Consent of Truist Securities, Inc. The Board of Directors Sanara MedTech Inc. 1200 Summit Avenue, Suite 414 Fort Worth, TX 76102 The Board of Directors: We hereby consent to the inclusion of our opinion letter, dated July 28, 2026, to the Board of Directors of Sanara MedTech Inc. (“Sanara”) as Annex C to, and reference to such opinion letter under the headings “SUMMARY - Opinion of Sanara’s Financial Adviso…
Read attachment ↗d791659dex991.htm · 8-K · 2025-01-14
EX-99.1 2 d791659dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Investor Presentation January 2025 Disclaimer & Cautionary Statements This presentation includes forward-looking statements. Forward-looking statements are subject to risks and uncertainties, and the Company cautions investors against placing undue reliance on such statements. Actual results may differ materially from those set forth in the forward-looking statements. Such forward-looking statements include statements regarding: • Fu…
Read attachment ↗